Æóҵչʾ

Ê×Ò³
¡¡¡ª¡¡Æóҵչʾ
¡¡¡ª¡¡ÆóÒµÐÂÎÅ

¿áÓιÙÍø-¿ÆÑ§¼Ò½ÒʾhPSCÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÓÚÌÇÄò²¡ÖÜΧÉñ¾­²¡±äµÄ¼²²¡½¨Ä£ºÍÒ©ÎïÑз¢

¿ÆÑ§¼ÒÕ¹ÏÖhPSCÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÔÚÌÇÄò²¡ÖÜΧ¾«Éñ²¡±äµÄ¼²²¡½¨Ä£¼°Ò©ÎïÑз¢

ÈÕÆÚ£º2023-05-25 À´Àú£º±¾Õ¾ ¹©¸å£ºÒ½Ò©ÉúÎï¼¼ÄÜ´¦ ×÷ÕߣºÖÎÀíÔ± ÖÖ±ð£ºÒëÎÄ

Ê©Íòϸ°û£¨Schwann cells£¬SC£©ÊÇÖÜΧÉñ¾­ÌåϵÖÐÖØÒªµÄ½ºÖÊϸ°û¡£SCÓëºÜ¶à¼²²¡Óйأ¬ÌÇÄò²¡ÖÜΧ¾«Éñ²¡±ä£¨Diabeticperipheral neuropathy£¬DPN£©ÊÇ´ËÖÐÖ®Ò»¡£ÃÀ¹ú¼ÓÖÝÄêҹѧ¾É½ðɽ·ÖУÑо¿Ö°Ô±·¢Ã÷£¬È˶àÄܸÉϸ°û£¨human pluripotent stem cell£¬hPSC£©ÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÔÚÌÇÄò²¡ÖÜΧ¾«Éñ²¡±äµÄ¼²²¡½¨Ä£¼°Ò©ÎïÑз¢¡£¸ÃÑо¿½á¹ûÔÚ½üÈÕ·¢±íÓÚ¡¶Cell Stem Cell¡·ÔÓÖ¾ÉÏ£¬ÌâΪ£ºDeriving Schwann cells fromhPSCs enables disease modeling and drug discovery for diabetic peripheralneuropathy¡£ Ñо¿Ö°Ô±Õ¹ÏÖÁËÒ»ÖÖ´ÓhPSCÑÜÉúSCµÄ¼ÆÄ±£¬´Ó¶ø¿ÉÒÔ»òÐíÖÜÈ«Ñо¿SCµÄ·¢Óý¡¢ÐÄÀíºÍÓë¼²²¡µÄ¹Ï¸ð¡£hPSCÑÜÉúµÄSCÔÙÏÖÁËÔ­´úSCµÄ·Ý×ÓÌØÐÔ£¬²¢¿áÓιÙÍø-¿ÉÒÔ»òÐíÓÚÌåÍâ¼°ÌåÄÚ¾ÙÐÐËèÇÊ»¯¡£ËûÃdzÉÁ¢ÁËÒ»¸öDPNÄ£×Ó£¬ÏÔʾSC¶ÔÓÚ¸ßѪÌǾ߱¸Ñ¡ÔñÒ×ËðÐÔ¡£ËûÃǾ­Óɹý³Ì¸ßͨÁ¿É¸Ñ¡·¢Ã÷£¬¿¹ÒÖÓôÒ©Îï°²·ÇËûͪÄܵÖÏûSCÖÐÆÏÌÑÌǵ;ÐÔ¡£Óð²·ÇËûͪҽÖθßѪÌǵÄСÊó¿ÉÒÔ±ÜÃâ¾õµÃ¹¦Ð§Õϰ­¡¢SCÃðÍö¼°ËèÇÊ»ÙÉË¡£ ×ÛÉÏ£¬hPSCÑÜÉúµÄÊ©Íòϸ°ûΪɸѡDPNµÄÒ½Öη½°¸ÌṩÁË¿Éѡģ×Ó¼°Ñо¿¶ÔÓÚÏó¡£ ×¢£º´ËÑо¿½á¹ûÕª×Ô¡¶Cell Stem Cell¡·ÔÓÖ¾£¬ÎÄÕÂÄÚÈݲ»´ú±í±¾ÍøÕ¾²»Ñŵ㼰̬¶È£¬½ö¹©²Î¿¼¡£-¿áÓιÙÍø-

»áÔ±µÇ¼

·µ»Ø¶¥²¿

×¢²á
¨w

ÐÕÃû*

¹«Ë¾Ãû³Æ*

ÓÊÏä*

µç»°ºÅÂë*

ÑéÖ¤Âë* »ñÈ¡ÑéÖ¤Âë

ÄúÏë×ÉѯµÄÒµÎñ*

怬
¨w

µç»°ºÅÂë*

ÑéÖ¤Âë* »ñÈ¡ÑéÖ¤Âë

×¢²áÕ˺Å

ÍêÉÆÐÅÏ¢
¨w

¹«Ë¾Ãû³Æ*

ÐÕÃû*

ÓÊÏä*

ÄúÏë×ÉѯµÄÒµÎñ*

¨w
×¢²áÐëÖª

×¢²áÕ˺Å

²¿·Ö±¾Æ½Ì¨·þÎñ½öÏò×¢²áÓû§Ìṩ£¬Èç¹ûÄúʹÓñ¾Æ½Ì¨ÌṩµÄÍøÂç´æ´¢¿Õ¼ä½øÐÐÊÓÌý¡¢ÎÄ×ÖµÈÄÚÈݵÄÉÏ´«¼°´«²¥µÈ£¬ÇëÏȸù¾Ý±¾Ð­Òé¼°ÆäËû±¾Æ½Ì¨¹æÔòÌáʾµÄ¹æÔò¡¢Á÷³Ì×¢²á³ÉΪע²áÓû§£¬²¢È·±£×¢²áÐÅÏ¢µÄÕæÊµÐÔ¡¢ÕýÈ·ÐÔ¼°ÍêÕûÐÔ£¬Èç¹ûÉÏÊö×¢²áÐÅÏ¢·¢Éú±ä»¯£¬ÄúÓ¦¼°Ê±¸ü¸Ä¡£

ÄúÓ¦¶Ô×¢²á»ñµÃµÄ±¾Æ½Ì¨Õ˺ţ¨ÒÔϼò³Æ¡°Õ˺𱣩ÏîϵÄÒ»ÇÐÐÐΪ³Ðµ£È«²¿ÔðÈΣ¬²»µÃÇÖ·¸°üÀ¨µ«²»ÏÞÓÚ±¾Æ½Ì¨ÔÚÄÚµÄÈκÎÖ÷ÌåµÄºÏ·¨È¨Òæ¡£

ÄúÀí½â²¢Í¬Ò⣬Äú½öÏíÓÐÕ˺ż°Õ˺ÅÏîÏÂÓɱ¾Æ½Ì¨ÌṩµÄÐéÄâ²úÆ·¼°·þÎñµÄʹÓÃȨ£¬Õ˺ż°¸ÃµÈÐéÄâ²úÆ·¼°·þÎñµÄËùÓÐȨ¹é±¾Æ½Ì¨ËùÓУ¨·¨ÂÉ·¨¹æÁíÓй涨µÄ³ýÍ⣩¡£Î´¾­±¾Æ½Ì¨ÊéÃæÍ¬Ò⣬Äú²»µÃÒÔÈκÎÐÎʽ´¦ÖÃÕ˺ŵÄʹÓÃȨ£¨°üÀ¨µ«²»ÏÞÓÚÔùÓë¡¢³ö½è¡¢×ªÈá¢ÏúÊÛ¡¢µÖѺ¡¢¼Ì³Ð¡¢Ðí¿ÉËûÈËʹÓã©¡£Èç¹û±¾Æ½Ì¨·¢ÏÖ»òÕßÓкÏÀíÀíÓÉÈÏΪʹÓÃÕß²¢·ÇÕ˺ųõʼע²áÈË£¬±¾Æ½Ì¨ÓÐȨÔÚ²»Í¨ÖªÄúµÄÇé¿öÏ£¬ÔÝÍ£»òÖÕÖ¹Ïò¸Ã×¢²áÕ˺ÅÌṩ·þÎñ£¬²¢×¢Ïú¸ÃÕ˺Å¡£

ÄúÓ¦Í×ÉÆ±£¹ÜÕ˺ÅÐÅÏ¢¡¢Õ˺ÅÃÜÂëÒÔ¼°ÆäËûÓëÕ˺ÅÏà¹ØµÄÐÅÏ¢¡¢×ÊÁÏ¡£ÈçÒòÄúµÄÔ­Òò£¬Ôì³ÉÕ˺ÅÐÅÏ¢¡¢×ÊÁÏ¡¢Êý¾ÝµÄ±ä¶¯¡¢Ãðʧ»ò²Æ²úËðʧµÈ£¬ÄúÓ¦Á¢¼´Í¨Öª±¾Æ½Ì¨²¢×ÔÐге£Ïà¹Ø·¨Âɺó¹û¡£



±¾Æ½Ì¨ÉϵÄÄÚÈÝ

±¾Æ½Ì¨ÉϵÄÄÚÈÝÊÇÖ¸¾­Óɱ¾Æ½Ì¨ÌṩµÄ·þÎñ£¬ÒÔÉÏ´«¡¢ÕÅÌù»òÈÎºÎÆäËû·½Ê½´«ËÍ»ò´«²¥µÄÈκÎ×ÊѶ¡¢×ÊÁÏ¡¢ÎÄ×Ö¡¢Èí¼þ¡¢ÒôÀÖ¡¢ÒôƵ¡¢ÕÕÆ¬¡¢Í¼ÐΡ¢ÊÓÆµ¡¢ÐÅÏ¢¡¢Á´½Ó»òÆäËû×ÊÁÏ£¬ÎÞÂÛϵ¹«¿ª»¹ÊÇ˽Ï´«ËÍ£¨ÒÔϼò³Æ¡°ÄÚÈÝ¡±£©£¬ÄÚÈÝÌṩÕß¡¢ÉÏ´«ÕßÓ¦¶ÔÆäÌṩ¡¢ÉÏ´«µÄÄÚÈݳе£È«²¿ÔðÈΣ¬Èç¹û¸ø±¾Æ½Ì¨Ôì³ÉËðʧµÄ£¬»¹Ó¦Ïò±¾Æ½Ì¨³Ðµ£Åâ³¥ÔðÈΡ£¶ÔÓÚµÚÈý·½ÒòÓû§ÉÏ´«µÄÄÚÈÝÏò±¾Æ½Ì¨Ö÷ÕÅȨÀûµÄ£¬±¾Æ½Ì¨ÓÐȨÔÚ²»ÊÂÏÈ֪ͨÄÚÈÝÌṩÕß¡¢ÉÏ´«ÕßµÄÇé¿öÏÂÖ±½Ó²Éȡɾ³ý¡¢ÆÁ±Î¡¢¶Ï¿ªÁ´½ÓµÈ±ØÒª´ëÊ©¡£

ÄúÔÚ±¾Æ½Ì¨ÉÏ´«»ò·¢²¼µÄÄÚÈÝ£¬Äú±£Ö¤¶ÔÆäÏíÓкϷ¨µÄÖø×÷Ȩ»òÏàÓ¦ÊÚȨ£¬±¾Æ½Ì¨ÓÐȨչʾ¡¢É¢²¼¼°ÍƹãǰÊöÄÚÈÝ¡£

ΪÌá¸ßÄúÄÚÈÝÆØ¹âÁ¿¼°·¢²¼Ð§ÂÊ£¬±¾Æ½Ì¨½«¶îÍâΪÄúÌṩȫÇò·¶Î§ÄÚµÄչʾºÍÍÆ¹ã·þÎñ£¬ÄúͬÒâÄúÔÚ±¾Æ½Ì¨µÄÕ˺ÅËù·¢²¼µÄÈ«²¿ÄÚÈݾùÊÚȨ±¾Æ½Ì¨ÒÔÄúµÄÕ˺Åͬ²½ÖÁ±¾Æ½Ì¨ÔËÓªµÄÈ«²¿²úÆ·£¬°üÀ¨µ«²»ÏÞÓÚPC¡¢Æ½°å¡¢ÊÖ»ú¡¢µçÊÓ¡¢»ú¶¥ºÐ¡¢¿É´©´÷É豸µÈÈ«²¿¿Í»§¶ËÈí¼þºÍ/»òÍøÕ¾¡£Í¬Ê±£¬ÄúÔÊÐí±¾Æ½Ì¨ÔÚͬ²½²¢Õ¹Ê¾ÄÚÈÝʱ¿É×ÔÐлòίÍеÚÈý·½½øÐбØÒªµÄ´¦Àí£¨°üÀ¨µ«²»ÏÞÓÚ·­Òë¡¢»ã±à¡¢¸Ä±àµÈ£©¡£ÄúÔÚ´ËÈ·Èϲ¢Í¬Ò⣬±¾Æ½Ì¨ÓÐȨ×ÔÐлòίÍеÚÈý·½ÔÚÓëÉÏÊöÄÚÈÝ¡¢±¾Æ½Ì¨²úÆ·¼°Ïà¹Ø·þÎñ¡¢±¾Æ½Ì¨ºÍ/»ò±¾Æ½Ì¨Æ·ÅÆÓйصÄÈκÎÐû´«¡¢ÍƹãºÍ/»òÑо¿ÖÐÒÔÊʵ±µÄ·½Ê½¿ª·¢ºÍʹÓÃÉÏÊöÄÚÈÝ£¨È«²¿»ò²¿·Ö£©¡£